Congenital Nonprogressive Hemangioma

Congenital nonprogressive hemangioma is a type of birthmark that is present at birth and does not change in size or appearance over time. It is a benign (non-cancerous) vascular lesion that results from an overgrowth of blood vessels in the skin. Hemangiomas can occur anywhere on the body but are most commonly found on the face, scalp, chest, and back.

Congenital nonprogressive hemangioma, also known as infantile hemangioma, is a benign (non-cancerous) tumor of blood vessels that is present at birth or develops soon after birth. It typically appears as a bright red or purplish bump or patch on the skin and can range in size from a few millimeters to several centimeters. Although it is not cancerous, it can cause a range of symptoms and complications depending on its size, location, and depth.

There are several different types of hemangiomas, including:

1. Strawberry hemangioma: This type of hemangioma is raised, bright red, and has a bumpy surface that resembles a strawberry. It is the most common type of hemangioma and is usually found on the face, scalp, chest, or back.
2. Cavernous hemangioma: This type of hemangioma is raised, but not as much as strawberry hemangioma. It has a dark red or purplish color and is soft to the touch. It is often found on the face, neck, or trunk.
3. Flat hemangioma: This type of hemangioma is not raised and has a flat, red, or purplish color. It is often found on the trunk or limbs.
4. Mixed hemangioma: This type of hemangioma is a combination of different types of hemangiomas, such as a strawberry and cavernous hemangioma.

Hemangiomas are classified as either superficial or deep. Superficial hemangiomas are found just under the skin and are the most common type of hemangioma. Deep hemangiomas are found deeper in the tissues and are less common.

Causes

Possible causes of congenital non-progressive hemangiomas.

1. Genetics: There is some evidence that suggests that congenital hemangiomas may have a genetic component. Certain genetic mutations have been found in individuals with hemangiomas, suggesting that the condition may be inherited.
2. Maternal factors: Certain maternal factors, such as smoking, alcohol consumption, and drug use, have been found to increase the risk of hemangiomas in infants.
3. Environmental factors: Exposure to certain environmental toxins, such as tobacco smoke, may also increase the risk of hemangiomas in infants.
4. Infections: Some infections, such as cytomegalovirus and rubella, have been linked to the development of congenital hemangiomas.
5. Vitamin deficiencies: Deficiencies in vitamins A and C have been linked to the development of hemangiomas.
6. Immune system dysfunction: Individuals with weakened immune systems, such as those with HIV, are at increased risk of developing hemangiomas.
7. Hormonal imbalances: Hormonal imbalances, such as an increase in estrogen levels, have been linked to the development of hemangiomas.
8. Blood flow issues: Abnormalities in blood flow, such as stenosis (narrowing) of blood vessels, can lead to the formation of hemangiomas.
9. Blood clotting disorders: Certain blood clotting disorders, such as von Willebrand disease, have been linked to the development of hemangiomas.
10. Inflammatory conditions: Inflammatory conditions, such as lupus and vasculitis, have been linked to the development of hemangiomas.
11. Trauma: Trauma to the skin, such as a cut or bruise, may increase the risk of hemangiomas.
12. Radiation exposure: Exposure to radiation, such as that from X-rays, may increase the risk of hemangiomas.
13. Medications: Certain medications, such as corticosteroids and aspirin, have been linked to the development of hemangiomas.
14. Age: Older individuals are at increased risk of developing hemangiomas.
15. Gender: Hemangiomas are more common in females than in males.
16. Family history: Individuals with a family history of hemangiomas are at increased risk of developing the condition.
17. Race: Hemangiomas are more common in individuals of African descent.
18. Chronic illnesses: Chronic illnesses, such as diabetes and heart disease, have been linked to the development of hemangiomas.
19. Autoimmune disorders: Autoimmune disorders, such as lupus and rheumatoid arthritis, have been linked to the development of hemangiomas.
20. Chronic exposure to certain chemicals: Chronic exposure to certain chemicals, such as pesticides and herbicides, may increase the risk of hemangiomas.

It is important to note that the exact cause of congenital non-progressive hemangiomas is not fully understood.

Symptoms

Possible symptoms of congenital nonprogressive hemangioma.

1. Visible Red or Purplish Bump or Patch: The most obvious symptom of congenital nonprogressive hemangioma is a visible bump or patch on the skin that is bright red or purplish in color. This bump can be raised or flat, and its size can range from a few millimeters to several centimeters.
2. Rapid Growth: In some cases, the hemangioma may grow rapidly in the first few weeks or months after birth, which can cause it to become larger and more noticeable.
3. Protrusion from the Surface of the Skin: In some cases, the hemangioma may bulge out from the surface of the skin, which can make it more noticeable and potentially uncomfortable.
4. Changes in Texture: The texture of the hemangioma can change over time, becoming softer or firmer, and this can also cause discomfort or pain.
5. Pain or Discomfort: Some people with hemangiomas may experience pain or discomfort in the affected area, which can range from mild to severe depending on the size and location of the hemangioma.
6. Itching: Some people with hemangiomas may experience itching in the affected area, which can be uncomfortable and distracting.
7. Bleeding: In rare cases, the hemangioma may bleed, which can cause significant discomfort and potentially even life-threatening complications.
8. Scarring: In some cases, the hemangioma may cause scarring, which can cause a permanent change in the appearance of the affected area.
9. Changes in Sensation: In some cases, the hemangioma may cause changes in sensation, such as numbness, tingling, or burning, which can be uncomfortable and distracting.
10. Impairment of Function: In some cases, the hemangioma may impair the function of nearby structures, such as the eyes, ears, nose, or mouth, which can cause significant discomfort and potentially even life-threatening complications.
11. Difficulty Breathing: In some cases, the hemangioma may interfere with breathing, which can cause significant discomfort and potentially even life-threatening complications.
12. Difficulty Eating or Swallowing: In some cases, the hemangioma may interfere with eating or swallowing, which can cause significant discomfort and potentially even life-threatening complications.
13. Impairment of Vision: In some cases, the hemangioma may impair vision, which can cause significant discomfort and potentially even life-threatening complications.
14. Impairment of Hearing: In some cases, the hemangioma may impair hearing, which can cause significant discomfort and potentially even life-threatening complications.
15. Impairment of Speech: In some cases, the hemangioma may impair speech, which can cause significant discomfort and potentially even life-threatening complications.
16. Changes in Appearance: In some cases, the hemangioma may cause significant changes in appearance, which can be distressing and potentially even

Diagnosis

Diagnosis of a congenital nonprogressive hemangioma typically involves a physical examination and a review of the patient’s medical history. Depending on the size and location of the hemangioma, additional tests may be recommended to confirm the diagnosis and assess the need for treatment.

The following are the common diagnostic tests and procedures used to diagnose a congenital nonprogressive hemangioma:

1. Physical examination: A physical examination by a healthcare provider is the first step in diagnosing a congenital nonprogressive hemangioma. The healthcare provider will examine the skin to look for any signs of a birthmark, such as a raised, red, or purplish bump. They may also check the location of the birthmark to determine if it is affecting any vital structures, such as the eyes or mouth.
2. Medical history: A review of the patient’s medical history is also important in diagnosing a congenital nonprogressive hemangioma. This may include questions about when the birthmark was first noticed, any changes in its appearance or size, and whether there is a family history of hemangiomas.
3. Ultrasound: An ultrasound is a non-invasive imaging test that uses high-frequency sound waves to create images of the inside of the body. This test can be used to confirm the diagnosis of a congenital nonprogressive hemangioma and to determine its size and location.
4. Magnetic Resonance Imaging (MRI): An MRI is an imaging test that uses a magnetic field and radio waves to create detailed images of the inside of the body. This test can be used to provide more information about the hemangioma, such as its depth and relationship to surrounding structures.
5. Biopsy: In some cases, a biopsy may be recommended to confirm the diagnosis of a congenital nonprogressive hemangioma. During a biopsy, a small sample of tissue is removed and examined under a microscope to look for the characteristic features of a hemangioma.
6. Doppler ultrasound: Doppler ultrasound is a type of ultrasound that uses sound waves to measure the flow of blood in the blood vessels. This test can be used to determine if the blood vessels in the hemangioma are functioning normally.

Treatment

The good news is that most hemangiomas will go away on their own and do not require treatment. However, in some cases, treatment may be necessary if the hemangioma is affecting the function of an organ, causing pain, or bleeding, or if it is affecting the child’s appearance.

The following are the different treatments that are available for congenital nonprogressive hemangiomas:

1. Observation: In many cases, observation is the best option as the hemangioma will go away on its own without the need for any treatment. The hemangioma will usually shrink and disappear within the first few years of life.
2. Topical Medications: Topical medications, such as corticosteroids, can be used to reduce the size of the hemangioma. Corticosteroids work by reducing the inflammation and blood flow to the hemangioma, causing it to shrink. Topical corticosteroids are often used in conjunction with other treatments, such as laser therapy.
3. Laser Therapy: Laser therapy is a non-invasive treatment that uses concentrated light to shrink the hemangioma. The laser works by destroying the overgrown blood vessels and reducing the size of the hemangioma. This treatment is usually performed in a dermatologist’s office and requires multiple sessions.
4. Surgical Excision: In some cases, surgical excision may be necessary to remove the hemangioma. This is typically only necessary if the hemangioma is affecting the function of an organ, such as the eye or ear, or if it is causing pain or bleeding. The surgery is typically performed under general anesthesia and may require skin grafting to cover the area after the hemangioma is removed.
5. Interventional Radiology: Interventional radiology is a minimally invasive treatment that uses specialized techniques to destroy the overgrown blood vessels. This can be done through embolization, which involves injecting a substance into the blood vessels to block their flow, or through sclerotherapy, which involves injecting a solution into the blood vessels to cause them to shrink.
6. Steroid Injections: Steroid injections can be used to shrink the hemangioma and reduce its size. The steroid is injected directly into the hemangioma and works by reducing the inflammation and blood flow to the area. This treatment is typically performed in a doctor’s office and may require multiple injections.
7. Propranolol: Propranolol is a beta-blocker that has been shown to be effective in treating certain types of hemangiomas. It works by reducing the blood flow to the hemangioma and slowing its growth. Propranolol is typically given orally and may need to be taken for several months.

It is important to note that each child is unique and the appropriate treatment for their hemangioma will depend on several factors, including its size, location, and the age of the child. A doctor or dermatologist will be able to recommend the best treatment option for your child based on their individual needs.

References